Omiganan vs Ponericin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Omiganan (CLS001, MBI-226) is a synthetic analog of indolicidin, a bovine neutrophil AMP. It was developed for topical antimicrobial applications including acne vulgaris, catheter-site infection prevention, and rosacea....
Calculate Omiganan dose →Ponericins are a family of antimicrobial peptides isolated from the venom of the ant Pachycondyla goeldii. They adopt alpha-helical conformations in membrane environments and display broad-spectrum antibacterial and insecticidal activity....
Calculate Ponericin dose →| Parameter | Omiganan | Ponericin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Completed) | Preclinical |
| Half-Life | Hours (topical) | Short |
| Typical Dose | 1-3% gel | N/A (research only) |
| Frequency | Twice daily | N/A |
| Route | Topical gel/cream | Topical / Systemic (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.